Gushengtang Holdings Limited

SHSC:2273 Stock Report

Market Cap: HK$7.8b

Gushengtang Holdings Valuation

Is 2273 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2273 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 2273 (HK$32) is trading below our estimate of fair value (HK$96.22)

Significantly Below Fair Value: 2273 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2273?

Key metric: As 2273 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 2273. This is calculated by dividing 2273's market cap by their current earnings.
What is 2273's PE Ratio?
PE Ratio27.4x
EarningsCN¥266.32m
Market CapCN¥7.30b

Price to Earnings Ratio vs Peers

How does 2273's PE Ratio compare to its peers?

The above table shows the PE ratio for 2273 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average37.1x
1951 Jinxin Fertility Group
23.7x19.6%HK$7.8b
9860 Adicon Holdings
19.5x20.2%HK$4.7b
6606 New Horizon Health
52.8x60.4%HK$6.3b
6667 Mega Genomics
52.2xn/aHK$1.8b
2273 Gushengtang Holdings
27.4x33.0%HK$7.8b

Price-To-Earnings vs Peers: 2273 is good value based on its Price-To-Earnings Ratio (27.4x) compared to the peer average (37.1x).

Price to Earnings Ratio vs Industry

How does 2273's PE Ratio compare vs other companies in the HK Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
574 Pa Shun International Holdings
1.8xn/aUS$8.36m
No more companies available in this PE range
2273 27.4xIndustry Avg. 12.1xNo. of Companies10PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 2273 is expensive based on its Price-To-Earnings Ratio (27.4x) compared to the Hong Kong Healthcare industry average (12.1x).

Price to Earnings Ratio vs Fair Ratio

What is 2273's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2273 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.4x
Fair PE Ratio19.4x

Price-To-Earnings vs Fair Ratio: 2273 is expensive based on its Price-To-Earnings Ratio (27.4x) compared to the estimated Fair Price-To-Earnings Ratio (19.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 2273 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$32.00
HK$58.21
+81.9%
14.8%HK$72.12HK$39.03n/a15
Dec ’25HK$33.80
HK$58.63
+73.5%
14.8%HK$72.77HK$39.38n/a15
Nov ’25HK$36.60
HK$61.77
+68.8%
13.4%HK$73.97HK$40.03n/a14
Oct ’25HK$45.10
HK$64.51
+43.0%
8.2%HK$74.87HK$53.12n/a14
Sep ’25HK$38.55
HK$63.88
+65.7%
8.5%HK$74.19HK$52.63n/a13
Aug ’25HK$33.75
HK$64.09
+89.9%
9.2%HK$74.23HK$52.37n/a13
Jul ’25HK$37.50
HK$64.29
+71.4%
9.2%HK$73.38HK$52.22n/a12
Jun ’25HK$42.15
HK$64.59
+53.2%
9.2%HK$73.76HK$52.49n/a12
May ’25HK$46.65
HK$64.69
+38.7%
9.3%HK$73.89HK$52.46n/a12
Apr ’25HK$43.60
HK$65.33
+49.8%
9.8%HK$73.91HK$52.47n/a12
Mar ’25HK$42.90
HK$66.63
+55.3%
11.6%HK$77.32HK$51.63n/a11
Feb ’25HK$36.70
HK$66.18
+80.3%
11.6%HK$77.45HK$51.72n/a11
Jan ’25HK$50.40
HK$65.85
+30.7%
10.6%HK$75.65HK$53.03n/a10
Dec ’24HK$50.50
HK$64.12
+27.0%
10.9%HK$74.07HK$51.93HK$33.8010
Nov ’24HK$47.80
HK$62.98
+31.8%
10.5%HK$73.55HK$51.56HK$36.6010
Oct ’24HK$44.15
HK$62.16
+40.8%
9.7%HK$70.58HK$51.54HK$45.1010
Sep ’24HK$41.55
HK$63.68
+53.3%
8.8%HK$71.26HK$52.04HK$38.5510
Aug ’24HK$48.30
HK$64.92
+34.4%
4.2%HK$69.50HK$60.79HK$33.759
Jul ’24HK$49.70
HK$65.28
+31.3%
5.4%HK$70.61HK$57.91HK$37.509
Jun ’24HK$48.00
HK$64.89
+35.2%
5.7%HK$70.55HK$57.85HK$42.159
May ’24HK$52.35
HK$66.03
+26.1%
6.0%HK$72.71HK$59.63HK$46.659
Apr ’24HK$56.85
HK$66.20
+16.4%
6.3%HK$73.18HK$60.01HK$43.608
Mar ’24n/a
HK$64.54
0%
8.4%HK$71.76HK$54.22HK$42.908
Feb ’24n/a
HK$57.55
0%
11.1%HK$67.19HK$46.07HK$36.706
Jan ’24n/a
HK$53.83
0%
12.6%HK$64.75HK$44.40HK$50.406
Dec ’23n/a
HK$50.35
0%
9.6%HK$57.59HK$43.53HK$50.506

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:29
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gushengtang Holdings Limited is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Qianyi LiChina International Capital Corporation Limited
Haohan XuChina Renaissance Securities